Receptors/proteins | Human BMV | Human brain | Human lung |
---|
TFRC | 1645.22 ± 249.68 | 1560.20 ± 520.04 | 7856.4 ± 6648.12 |
INSR | 3010.84 ± 1158.90* | 854.14 ± 81.00 | 1260.72 ± 106.44 |
IGF1R | 1304.87 ± 746.61 | 905.46 ± 229.11 | 800.57 ± 198.75 |
IGF2R | 602.08 ± 550.37 | 613.27 ± 194.15 | 4162.89 ± 2237.01* |
LRP1 | 6896.83 ± 2520.15 | 5797.91 ± 1220.33 | 12,733.83 ± 4968.54 |
LDLR | 1424.41 ± 2003.73* | 294.13 ± 121.19 | 6952.95 ± 2791.13 |
LRP8 (ApoER2) | 695.27 ± 650.56 | 734.55 ± 153.52 | 116.66 ± 69.72 |
CDC50A/TMEM30A | 5578.82 ± 1174.14 | 7977.31 ± 2267.54 | 7621.38 ± 3189.82 |
SLC2A1/GLUT1 | 9579.89 ± 7741.88# | 3110.7 ± 1033.78 | 472.20 ± 217.86 |
SLC3A2/CD98hc | 6527.14 ± 3983.38 | 4619.39 ± 509.35 | 5088.29 ± 425.63 |
LEPR | 1131.17 ± 617.91* | 1932.75 ± 612.91 | 3549.49 ± 132.05 |
- Comparison of gene expression (transcript abundance) across isolated human BMVs, brain and lung was performed using One-way ANOVA, followed by Tukey’s multiple comparisons test. Significant difference was indicated by (*). For simplicity, statistical significance was shown only for comparisons of BMV against other tissues (but not among other tissues)
- *INSR expression in BMV was significantly (p < 0.05) higher compared to either brain or lung
- *IGF2R expression in lung tissue was significantly (p < 0.05) higher compared to either brain vessels or brain
- *LDLR expression in BMV was significantly higher (p < 0.001) compared to brain and significantly lower (p < 0.05) compared to lung
- #SLC2A1/GLUT1: one sample out of 3 showed low transcript level, causing high SD. Therefore, despite overall high abundance, there was no significant difference compared to brain and lung. *LEPR expression in BMV was significantly lower compared to lung (p < 0.001)